Seegene, 757,052 Shares Net Bought by Individuals in Last 5 Days... Stock Price 226,000 KRW (+0.13%)

As of 10:30 AM on the 13th, Seegene is trading at 226,000 KRW, up 0.13% from the previous day. The trading volume is 822,060 shares, which is 31.48% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On November 12, Kim Choonghyun, a researcher at Mirae Asset Daewoo, stated, "After Pfizer's COVID-19 vaccine data announcement, sentiment for in vitro diagnostics deteriorated sharply. Considering the trend in confirmed COVID-19 cases and the order backlog for diagnostic equipment, no rapid decrease in demand for diagnostic kits has been detected. Major diagnostic companies emphasized supply shortages in their earnings reports. Given the time lag until the COVID-19 vaccine receives final approval and mass production begins, the likelihood of a rapid decline in COVID-19 infections appears very low." He set Seegene's target price at 275,800 KRW.

Over the past five days, individual investors have net purchased 757,052 shares of Seegene, while foreigners and institutions have net sold 479,148 shares and 289,157 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.